The current financial score of Elanco Animal Health Inc is 8.74. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 1.37B, representing a year-over-year increase of 10.23%, while its net profit experienced a year-over-year increase of 390.91%.
The current valuation score of Elanco Animal Health Inc is 9.19. Its current P/E ratio is -46.58, which is -882.96% below the recent high of 364.72 and -360.24% above the recent low of -214.39.
The current earnings forecast score of Elanco Animal Health Inc is 8.82. The average price target is 31.14, with a high of 34.00 and a low of 26.00.
The current price momentum score of Elanco Animal Health Inc is 3.01. Currently, the stock price is trading between the resistance level at 24.55 and the support level at 21.79, making it suitable for range-bound swing trading.
The current institutional shareholding score of Elanco Animal Health Inc is 10.00. The latest institutional shareholding proportion is 109.98%, representing a quarter-over-quarter decrease of 8.68%. The largest institutional shareholder is Van Duyn Dodge & E. Morris Cox, holding a total of 67.40M shares, representing 0.87% of shares outstanding, with 10.11% decrease in holdings.
The current risk assessment score of Elanco Animal Health Inc is 6.50. The company's beta value is 1.70. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.